Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiber Supplementation and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
NCT04578652Phase 3Recruiting
- Sponsor
- University of Alberta
- Start
- Oct 2021
- Primary completion
- Feb 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in obesity, insulin resistance (IR), sponsored by University of Alberta. Started Oct 2021; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesityinsulin resistance (IR)
Beyond the preview
Go deeper on NCT04578652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04578652.